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on health related quality of life. Attention is needed to highlight determinants of 
health related quality of life and to implement policies for better management of 
Type 2 Diabetes Mellitus, particularly in early treatment phases where improving 
Health Related Quality of Life is still possible.
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Objectives: Diabetic foot ulcer (DFU) is a common complication of diabetes and 
not only an important factor of mortality among patients with diabetes but also 
decreases quality of life. Several clinical trials showed that patients with foot 
ulceration have significantly decreased HRQoL as compared to those without 
DFU. Most of these studies used SF-36 for quality of life measures, however it is 
suggested that the results of this HRQoL survey may be confounded by non-foot 
complications of diabetes. The short form of Diabetic Foot Ulcer Scale (DFS-SF) is 
a condition-specific tool, providing comprehensive measurement of DFU impact 
on patients’ QoL. The Polish translation of DFS-SF has undergone a full linguistic 
validation process and showed good psychometric performance in patients with 
DFU. The purpose of this study was to investigate the influence of ulcers healing 
process on HRQoL. MethOds: Assessment of healing process impact on HRQoL 
was performed in patients with active DFU. Wound healing assessment was car-
ried out on two control visits separated with a 6-months period, on the basis of 
wound diameter measurements and PEDIS score. Hypothesis testing was conducted 
using the Student’s t-test (α = 0.05). Results: Data on 120 patients were analyzed 
(mean age: 61.1 years, male: 73%, type 2 diabetes: 87%). The average ulcer size on 
first visit was 5.6 sq cm, and reduced significantly to 2.7 sq cm on second visit. 
Improvement in all six DFS-SF subscales was observed, statistically significant in 
physical health, worried about ulcers/feet and bothered by ulcer care subscales. 
Complete ulcer healing was observed in 42 patients. All six DFS-SF subscales showed 
greater improvement in this subpopulation compared to population without com-
plete ulcer healing, although the difference was not significant. cOnclusiOns: 
In previous study we identified weak negative correlation between ulcer size and 
HRQoL. This study showed that ulcers healing process has significant impact on 
HRQoL of DFU patients.
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Objectives: Understanding immediate improvements in health related quality-
of-life (HRQoL) due to better glycaemic control may help inform decisions relating 
to the management of diabetes. This study investigated the short-term impact on 
HRQoL associated with HbA1c change, body weight change, and the complexity of 
treatment regimen, using time-trade-off (TTO) methodology MethOds: The study 
was performed in three stages: 1) Qualitative telephone interviews with people 
with type 2 diabetes (T2D) in Denmark who experienced a decrease in their HbA1c 
level; 2) A validation survey with people with T2D in Denmark to obtain quantifiable 
knowledge on the short-term effects of a change in HbA1c levels; 3) TTO survey using 
health states based on results from stage 2. ‘Not well-controlled diabetes’ reflected 
an HbA1c average of 11.6%, and ‘well-controlled diabetes’ an HbA1c average of 
7.4%. All other health states were based on ‘well-controlled diabetes’. These health 
states implied change in insulin regimen and change in weight. Respondents were 
either adults with T2D (Sweden) or from the general public (UK and Denmark) and 
were separately randomly allocated to evaluate 6 of the 10 health states through an 
internet-based survey. Results: In total, 4060respondents were available for analy-
sis (UK n= 1777; Denmark n= 1799, Sweden n= 484). ‘Well-controlled diabetes’ was 
associated with a utility of 0.85-0.91 and ‘not well-controlled diabetes’ with utilities 
of 0.71-0.80. The treatment regimen health state associated with the smallest reduc-
tion in utility was the once-daily insulin regimen. As expected, results in all three 
countries suggested that respondents would prefer to lose rather than gain weight 
(utility of 0.87–0.92 for losing 5 kg and 0.88–0.92 for losing 2 kg). cOnclusiOns: A 
simple treatment regimen with fewer injections that improves HbA1c levels, avoids 
weight gain, or even causes weight loss, compared with other treatments, will have 
a positive impact on HRQoL.
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Objectives: The aim of this study was to estimate willingness to pay (WTP) amount 
for one quality adjusted-life years (QALY) in diabetic patients and investigating fac-
tors that associated with it. MethOds: A cross sectional survey with face to face 
interviews was conducted with diabetic patients in Tehran city between June and 
August of 2014 to elicit WTP for QALY as following: First, Current health preferences 
were measured using EuroQol-5D (EQ-5D), visual analogue Scale (VAS) and time 
trade off (TTO) techniques, then a hypothetical scenario using double bounded 
dichotomous choice technique was presented to patients to elicit individual’s maxi-
mum WTP for a treatment that recovering them to full health ,contingent to be 
available. finally, value of QALY was estimated by combining preferences. A regres-
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Objectives: Last few years there is drastic increase in type 2 DM cases especially in 
India. Quality of life is considered as one of the better assessment for management 
of diabetes in recent years. The main objective of the study was to assess the HRQOL 
among the diabetes patients using the EQ-5D (kannada version) and to correlate 
with patient demography, complications and treatment. MethOds: The study was 
carried out in medicine Out Patient Department of a tertiary care hospital for the 
period of 6 months. Patients who have fulfilled the inclusion criteria were enrolled 
in the study and demographical details like name, age, sex, occupation, and medical 
and medication history were collected from the medical record. Patients were inter-
viewed and EQ-5D-3L questionnaire was administered. Data was analysed using 
SPSS ver 20.0. Results: Total of 120 patients were selected as per the inclusion 
criteria, among them majority were males (60% N-72) and mean age was 56.8±10.3 
years.The mean value of TTO and VAS was 0.707± 0.2 and 0.688± 0.16 respectively. 
There was statistically significant relationship between HbA1c level and EQ-5D 
score (p< 0.05). Patients suffering from HTN and cardiovascular complications have 
lower EQ-5D scores than the mean scores, and was statistically significant for HTN 
(p< 0.05). There was significant relationship between EQ-5D score and the presence 
of neuropathy and retinopathy (p< 0.05). Patients with increased number of sub-
jective symptoms such as lethargy, fatigue, body pain, weight loss etc. have lower 
EQ-5D scores (p< 0.05). cOnclusiOns: We observed age wise increase in prevalence 
of diabetes mainly in males. Patient with increased age, increased HbA1C levels, 
presence of complications and increased number of diabetic symptoms showed 
increased problems with different dimensions of EQ-5D. We also observed increased 
age, increased HBA1C, presence of complications and increased number of diabetes 
symptoms will decrease the TTO and VAS scores.
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bAckgROund: Previous studies in patients with primary adrenal insufficiency (PAI) 
on conventional replacement therapy suggest decreased health-related quality of 
life (HRQoL), and that patients report more frequently fatigue, increased anxiety 
and inability to work compared to background population. Objectives: To study 
self-reported health status with EQ-5D in patients with PAI. Patients treated with 
Plenadren (modified-release hydrocortisone) were compared with patients treated 
with immediate release hydrocortisone (IRHC) replacement therapy. MethOds: 
This was a cross-sectional, multi-centre, non-interventional survey of patients 
with PAI receiving Plenadren or immediate release hydrocortisone (IRHC) replace-
ment. subjects: One hundred thirty-four adult patients with PAI of whom 
36 (19 females [53%]) were treated with Plenadren and 98 (77 females [79%]) were 
treated with IRHC, were included. MAin OutcOMe MeAsuRe: HRQoL described 
by the EQ-5D, a generic preference-based measure of health. Results: Patients 
on Plenadren and on IRHC had a mean ± SD age of 53.1 ± 12.7 years and 48.0 ± 13.1 
years, respectively (P= 0.043). The majority of the patients were diagnosed more 
than 5 years ago (69%). The mean ± SD daily Plenadren and IRHC doses were 27.0 ± 
6.8 mg and 26.6 ± 10.9 mg, respectively (P= 0.807). 47% of the Plenadren patients had 
been receiving Plenadren and 82% of the IRHC patients had been receiving IRHC 
for more than 3 years. Patients receiving Plenadren had better HRQoL measured 
by the EQ-5D questionnaire compared to patients replaced with IRHC (0.76 ± 0.18 
vs 0.68 ± 0.18, respectively [P= 0.040]). cOnclusiOns: Replacement therapy with 
Plenadren in patients with PAI confers measurable benefit on HRQoL relative to 
IRHC as estimated by the EQ-5D questionnaire, and may therefore be advantageous 
when compared to IRHC substitution.
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Objectives: This study was aimed to describe the Health Related Quality of 
Life profile of Type 2 Diabetes Mellitus population attending outpatient clinics in 
Pakistan. MethOds: The study was designed as a cross-sectional descriptive sur-
vey. Type 2 diabetic patients attending a tertiary care institute in Sargodha, Pakistan 
were targeted for the study. The EuroQol EQ-5D was used for the assessment of 
Health Related quality of Life and was scored using values derived from the UK 
general population survey. Descriptive statistics were used for the elaboration 
of socio-demographic characteristics. The chi-square test was used to depict the 
possible association between study variables and Health Related Quality of Life. 
Where significant associations were noted, Phi and Cramer’s V constant were used 
for data interpretation accordingly. P < 0.05 was taken as significant. Results: 
Three hundred and ninety two patients were approached for the study. The 
cohort was dominated by males (n= 222, 56.60 %) with 5.58±4.09 years of history 
of Type 2 Diabetes Mellitus. The study highlighted poor Health related Quality of 
Life among patients with Type 2 Diabetes Mellitus (0.471 ± 0.336). Gender, marital 
status, education, monthly income, occupation, location and duration of the dis-
ease was reported to be significantly associated with Health Related Quality of 
Life (P< 0.001). cOnclusiOns: Type 2 Diabetes Mellitus imposes a negative effect 
